ARQT · Categories · Upgrades

ARQT - Analyst upgrades

Arcutis Biotherapeutics Inc. (ARQT) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for ARQT

• 926d
  Arcutis Biotherapeutics upgraded by Mizuho with a new price target

  Mizuho upgraded Arcutis Biotherapeutics from Neutral to Buy and set a new price target of $8.00 from $4.00 previously
• 1877d
  Arcutis Biotherapeutics upgraded by Morgan Stanley with a new price target

  Morgan Stanley upgraded Arcutis Biotherapeutics from Equal-Weight to Overweight and set a new price target of $52.00

Other ARQT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings